Search research articles
Contact Us
Filters
Showing results (441-450 of 461) with videos related to
Page
of 47
Sort By:
The Journal of Infectious Diseases
|
July 25, 2024
Integrated Analysis of Patient Networks and Plasmid Genomes to Investigate a Regional, Multispecies Outbreak of Carbapenemase-Producing Enterobacterales Carrying Both blaIMP and mcr-9 Genes
Yu Wan, Ashleigh C Myall, Adhiratha Boonyasiri, et al.
The Lancet. Gastroenterology & Hepatology
|
October 15, 2019
Safety of two different doses of simvastatin plus rifaximin in decompensated cirrhosis (LIVERHOPE-SAFETY): a randomised, double-blind, placebo-controlled, phase 2 trial
Elisa Pose, Laura Napoleone, Ahmed Amin, et al.
Journal of Clinical and Translational Hepatology
|
June 11, 2026
Consensus versus Outcome-based Definitions of Acute-on-chronic Liver Failure: Implications for Risk Stratification and Case Identification
Nipun Verma, Tingting Qi, Pratibha Garg, et al.
Hepatology Communications
|
December 29, 2021
Treatment With Simvastatin and Rifaximin Restores the Plasma Metabolomic Profile in Patients With Decompensated Cirrhosis
Elisa Pose, Elsa Solà, Juan J Lozano, et al.
Gastroenterology
|
January 21, 2014
A histologic scoring system for prognosis of patients with alcoholic hepatitis
José Altamirano, Rosa Miquel, Aezam Katoonizadeh, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 6, 2017
Dabrafenib plus trametinib versus dabrafenib monotherapy in patients with metastatic BRAF V600E/K-mutant melanoma: long-term survival and safety analysis of a phase 3 study
G V Long, K T Flaherty, D Stroyakovskiy, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
|
July 4, 2021
PRAISE: providing a roadmap for automated infection surveillance in Europe
Maaike S M van Mourik, Stephanie M van Rooden, Mohamed Abbas, et al.
European Heart Journal. Quality of Care & Clinical Outcomes
|
December 8, 2025
Paediatric pulmonary arterial hypertension following congenital heart defect repair: Enhanced risk stratification and outcomes in a national cohort
Andrew Constantine, Konstantinos Dimopoulos, Robin Condliffe, et al.
Lancet (London, England)
|
June 4, 2015
Dabrafenib and trametinib versus dabrafenib and placebo for Val600 BRAF-mutant melanoma: a multicentre, double-blind, phase 3 randomised controlled trial
Georgina V Long, Daniil Stroyakovskiy, Helen Gogas, et al.
Gut
|
October 26, 2023
Novel prognostic biomarkers in decompensated cirrhosis: a systematic review and meta-analysis
Adrià Juanola, Ann Thu Ma, Koos de Wit, et al.
Page
of 47
Search research articles
Search
Showing results (441-450 of 461) with videos related to
Sort By:
Page
of 47
The Journal of Infectious Diseases
|
July 25, 2024
Integrated Analysis of Patient Networks and Plasmid Genomes to Investigate a Regional, Multispecies Outbreak of Carbapenemase-Producing Enterobacterales Carrying Both blaIMP and mcr-9 Genes
Yu Wan, Ashleigh C Myall, Adhiratha Boonyasiri, et al.
The Lancet. Gastroenterology & Hepatology
|
October 15, 2019
Safety of two different doses of simvastatin plus rifaximin in decompensated cirrhosis (LIVERHOPE-SAFETY): a randomised, double-blind, placebo-controlled, phase 2 trial
Elisa Pose, Laura Napoleone, Ahmed Amin, et al.
Journal of Clinical and Translational Hepatology
|
June 11, 2026
Consensus versus Outcome-based Definitions of Acute-on-chronic Liver Failure: Implications for Risk Stratification and Case Identification
Nipun Verma, Tingting Qi, Pratibha Garg, et al.
Hepatology Communications
|
December 29, 2021
Treatment With Simvastatin and Rifaximin Restores the Plasma Metabolomic Profile in Patients With Decompensated Cirrhosis
Elisa Pose, Elsa Solà, Juan J Lozano, et al.
Gastroenterology
|
January 21, 2014
A histologic scoring system for prognosis of patients with alcoholic hepatitis
José Altamirano, Rosa Miquel, Aezam Katoonizadeh, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 6, 2017
Dabrafenib plus trametinib versus dabrafenib monotherapy in patients with metastatic BRAF V600E/K-mutant melanoma: long-term survival and safety analysis of a phase 3 study
G V Long, K T Flaherty, D Stroyakovskiy, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
|
July 4, 2021
PRAISE: providing a roadmap for automated infection surveillance in Europe
Maaike S M van Mourik, Stephanie M van Rooden, Mohamed Abbas, et al.
European Heart Journal. Quality of Care & Clinical Outcomes
|
December 8, 2025
Paediatric pulmonary arterial hypertension following congenital heart defect repair: Enhanced risk stratification and outcomes in a national cohort
Andrew Constantine, Konstantinos Dimopoulos, Robin Condliffe, et al.
Lancet (London, England)
|
June 4, 2015
Dabrafenib and trametinib versus dabrafenib and placebo for Val600 BRAF-mutant melanoma: a multicentre, double-blind, phase 3 randomised controlled trial
Georgina V Long, Daniil Stroyakovskiy, Helen Gogas, et al.
Gut
|
October 26, 2023
Novel prognostic biomarkers in decompensated cirrhosis: a systematic review and meta-analysis
Adrià Juanola, Ann Thu Ma, Koos de Wit, et al.
Page
of 47